The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,4-Dihydro-3'-(4-methylphenylsulfonyl)spiro[imidazoline-5',1(2H)-naphthalene]-2',4'-dione ID: ALA4532536
PubChem CID: 155547724
Max Phase: Preclinical
Molecular Formula: C19H18N2O4S
Molecular Weight: 370.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(S(=O)(=O)N2C(=O)NC3(CCCc4ccccc43)C2=O)cc1
Standard InChI: InChI=1S/C19H18N2O4S/c1-13-8-10-15(11-9-13)26(24,25)21-17(22)19(20-18(21)23)12-4-6-14-5-2-3-7-16(14)19/h2-3,5,7-11H,4,6,12H2,1H3,(H,20,23)
Standard InChI Key: LXXQXOMQCGHKBG-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
25.1142 -1.9481 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8241 -2.3566 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
25.8230 -1.5376 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.6438 -2.3576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4180 -3.0653 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.6008 -3.0652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3482 -3.8424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0093 -4.3228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6704 -3.8425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8882 -4.7380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8870 -5.5576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5951 -5.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5933 -4.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3019 -4.7344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3008 -5.5551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0070 -5.9641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7188 -5.5571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7200 -4.7364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4475 -4.0951 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.1205 -2.4040 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.0479 -3.0680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8643 -3.0684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2737 -2.3601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8608 -1.6501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0457 -1.6532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0909 -2.3591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
2 4 1 0
2 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
10 11 2 0
11 12 1 0
12 15 2 0
14 13 2 0
13 10 1 0
14 15 1 0
14 8 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 8 1 0
9 19 2 0
6 20 2 0
4 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 4 1 0
23 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 370.43Molecular Weight (Monoisotopic): 370.0987AlogP: 2.47#Rotatable Bonds: 2Polar Surface Area: 83.55Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.87CX Basic pKa: ┄CX LogP: 3.60CX LogD: 3.60Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.82Np Likeness Score: -0.93
References 1. Iqbal Z, Morahan G, Arooj M, Sobolev AN, Hameed S.. (2019) Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress., 168 [PMID:30818176 ] [10.1016/j.ejmech.2019.02.036 ]